Promethazine
Brand names: Meperidine Hydrochloride and Promethazine Hydrochloride, PHENERGAN, PROMETHAZINE HYDROCHLORIDE, Promethazine HCl, Promethazine Hydrochloride, Promethazine hydrochloride, promethazine hydrochloride, Promethazine
Warnings
BOXED WARNING: "Promethazine hydrochloride should not be used in pediatric patients less than 2 years of age because of the potential for fatal respiratory depression," and caution is advised in older pediatric patients because fatal respiratory depression has occurred even at recommended doses. Other key warnings/contraindications: comatose states and hypersensitivity to phenothiazines; respiratory depression risk in patients with compromised respiratory function (e.g., COPD, sleep apnea); CNS/psychomotor impairment affecting driving; lowered seizure threshold; and risk of neuroleptic malignant syndrome.
Contraindications
CONTRAINDICATIONS Promethazine hydrochloride tablets, USP are contraindicated for use in pediatric patients less than two years of age. Promethazine hydrochloride tablets, USP are contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms including asthma.
Overdose
OVERDOSAGE Signs and symptoms of overdosage with promethazine hydrochloride range from mild depression of the central nervous system and cardiovascular system to profound hypotension, respiratory depression, unconsciousness, and sudden death. Other reported reactions include hyperreflexia, hypertonia, ataxia, athetosis, and extensorplantar reflexes (Babinski reflex). Stimulation may be evident, especially in children and geriatric patients. Convulsions may rarely occur. A paradoxical-type reaction has been reported in children receiving single doses of 75 mg to 125 mg orally, characterized by hyperexcitability and nightmares. Atropine-like signs and symptoms—dry mouth, fixed, dilated pupils, flushing, as well as gastrointestinal symptoms - may occur. Treatment Treatment of overdosage is essentially symptomatic and supportive. Only in cases of extreme overdosage or individual sensitivity do vital signs, including respiration, pulse, blood pressure, temperature, and EKG, need to be monitored. Activated charcoal orally or by lavage may be given, or sodium or magnesium sulfate orally as a cathartic. Attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and institution of assisted or controlled ventilation. Diazepam may be used to control convulsions. Acidosis and electrolyte losses should be corrected. Note that any depressant effects of promethazine hydrochloride are not reversed by naloxone. Avoid analeptics which may cause convulsions. The treatment of choice for resulting hypotension is administration of intravenous fluids, accompanied by repositioning if indicated. In the event that vasopressors are considered for the management of severe hypotension which does not respond to intravenous fluids and repositioning, the administration of norepinephrine or phenylephrine should be considered. EPINEPHRINE SHOULD NOT BE USED, since its use in patients with partial adrenergic blockade may further lower the blood pressure. Extrapyramidal reactions may be treated with anticholinergic antiparkinsonian agents, diphenhydramine, or barbiturates. Oxygen may also be administered. Limited experience with dialysis indicates that it is not helpful.
Uses
Promethazine Hydrochloride Tablets are indicated for allergic conditions such as perennial and seasonal allergic rhinitis, allergic conjunctivitis, urticaria, and angioedema; amelioration of allergic reactions to blood or plasma; dermographism; anaphylaxis as adjunctive therapy; active and prophylactic treatment of motion sickness; prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery; sedation and relief of apprehension with production of light sleep; and as an adjunct to analgesics for postoperative pain control.
Dosage forms & strengths
DOSAGE AND ADMINISTRATION Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age (see WARNINGS - Black Box Warning and Use in Pediatric Patients ). Promethazine hydrochloride tablets, USP are for oral administration only. Allergy The average oral dose is 25 mg taken before retiring; however, 12.5 mg may be taken before meals and on retiring, if necessary. Single 25 mg doses at bedtime or 6.25 mg to 12.5 mg taken three times daily will usually suffice. After initiation of treatment in children or adults, dosage should be adjusted to the smallest amount adequate to relieve symptoms. The administration of promethazine hydrochloride in 25 mg doses will control minor transfusion reactions of an allergic nature. Motion Sickness The average adult dose is 25 mg taken twice daily. The initial dose should be taken one-half to one hour before anticipated travel and be repeated 8 to 12 hours later, if necessary. On succeeding days of travel, it is recommended that 25 mg be given on arising and again before the evening meal. For children, promethazine hydrochloride tablets, USP 12.5 mg to 25 mg, twice daily, may be administered. Nausea and Vomiting Antiemetics should not be used in vomiting of unknown etiology in children and adolescents (see WARNINGS - Use in Pediatric Patients ). The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of nausea and vomiting in children or adults is 25 mg. 12.5 to 25 mg doses may be repeated, as necessary, at 4 to 6 hour intervals. For nausea and vomiting in children, the usual dose is 0.5 mg per pound of body weight, and the dose should be adjusted to the age and weight of the patient and the severity of the condition being treated. For prophylaxis of nausea and vomiting, as during surgery and the postoperative period, the average dose is 25 mg repeated at 4 to 6 hour intervals, as necessary. Sedation This product relieves apprehension and induces a quiet sleep from which the patient can be easily aroused. Administration of 12.5 to 25 mg promethazine hydrochloride orally at bedtime will provide sedation in children. Adults usually require 25 to 50 mg for nighttime, presurgical, or obstetrical sedation. Pre- and Postoperative Use Promethazine hydrochloride tablets, USP in 12.5 to 25 mg doses for children and 50 mg doses for adults the night before surgery relieves apprehension and produces a quiet sleep. For preoperative medication, children require doses of 0.5 mg per pound of body weight in combination with an appropriately reduced dose of narcotic or barbiturate and the appropriate dose of an atropine-like drug. Usual adult dosage is 50 mg promethazine hydrochloride tablets, USP with an appropriately reduced dose of narcotic or barbiturate and the required amount of a belladonna alkaloid. Postoperative sedation and adjunctive use with analgesics may be obtained by the administration of 12.5 to 25 mg in children and 25 to 50 mg doses in adults. Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age.
All identified pills
107
PINK ROUND · Promethazine
5 manufacturers
108
WHITE ROUND · Promethazine
12 manufacturers
109
PINK ROUND · Promethazine
2 manufacturers
5136 V
PINK ROUND · Promethazine
5137 V
WHITE ROUND · Promethazine
10 manufacturers
5138 V
ORANGE ROUND · Promethazine
2 manufacturers
622
RED CAPSULE · Promethazine
AN 522
PINK ROUND · Promethazine
4 manufacturers
AN 745
WHITE ROUND · Promethazine
11 manufacturers
AN 521
WHITE ROUND · Promethazine
32 manufacturers
C51
WHITE ROUND · Promethazine
C52
WHITE ROUND · Promethazine
3 manufacturers
C53
WHITE ROUND · Promethazine
2 manufacturers
DAN DAN
WHITE ROUND · Promethazine
30 manufacturers
DAN 5319
WHITE ROUND · Promethazine
GG 235
PINK ROUND · Promethazine
2 manufacturers
GG 225
WHITE ROUND · Promethazine
9 manufacturers
HP 67
ORANGE ROUND · Promethazine
HP68
WHITE ROUND · Promethazine
HP69
PINK ROUND · Promethazine
K 4
PINK ROUND · Promethazine
3 manufacturers
K 2
ORANGE ROUND · Promethazine
8 manufacturers
K 3
WHITE ROUND · Promethazine
26 manufacturers
K3
WHITE ROUND · Promethazine
M PT
WHITE ROUND · Promethazine
M PT
WHITE ROUND · Promethazine
M PT
WHITE ROUND · Promethazine
P 125
WHITE ROUND · Promethazine
P 25
WHITE ROUND · Promethazine
P50
WHITE ROUND · Promethazine
Z C
WHITE ROUND · Promethazine
19 manufacturers
ZC 01
WHITE ROUND · Promethazine
9 manufacturers
ZC02
WHITE ROUND · Promethazine
3 manufacturers
ZC03
WHITE ROUND · Promethazine
4 manufacturers
Side effects
Common adverse reactions include drowsiness/sedation, blurred vision, dizziness, and dry mouth. Serious reactions include potentially fatal respiratory depression (especially in young children or with concomitant CNS depressants), extrapyramidal symptoms, hallucinations and confusion, convulsions, leukopenia and agranulocytosis, neuroleptic malignant syndrome, and cardiovascular effects such as hypotension, hypertension, and tachycardia.